Kura Oncology Inc at JMP Securities Life Sciences Conference Transcript
Good afternoon, everyone, and welcome. It's my pleasure to introduce Kura Oncology, a leader in the menin and transferase inhibitor space -- farnesyl transferase inhibitor space. Presenting for the company is Troy Wilson. Welcome, Troy, remotely.
But you know how I'd like to do these talks. I'd love for you to kind of level set the audience first because I never know who is listening in for the first time. Can you tell us a little bit about Kura Oncology? And then we can dig into some of the details.
Sure, Ren. Good afternoon and thank you to you and JMP for the invitation to the conference. I'm sorry I couldn't be there in person.
For the audience's benefit, I am recovering from COVID and thought it best to keep everybody safe. But you were very kind to make arrangements to have me join you remotely.
As far as Kura, as you laid out nicely, Ren, we are in the targeted oncology space. Three principal pillars to the business: our menin
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
